PMID- 37716626
OWN - NLM
STAT- MEDLINE
DCOM- 20240319
LR  - 20240319
IS  - 1526-3231 (Electronic)
IS  - 0749-8063 (Linking)
VI  - 40
IP  - 4
DP  - 2024 Apr
TI  - Establishing the Minimal Clinically Important Difference and Patient Acceptable 
      Symptom State Thresholds Following Arthroscopic Capsular Release for the 
      Treatment of Idiopathic Shoulder Adhesive Capsulitis.
PG  - 1081-1088
LID - S0749-8063(23)00770-3 [pii]
LID - 10.1016/j.arthro.2023.08.083 [doi]
AB  - PURPOSE: To determine the minimal clinically important difference (MCID) and the 
      patient acceptable symptom state (PASS) threshold for the visual analog scale 
      (VAS), Constant, Single Assessment Numeric Evaluation (SANE), and American 
      Shoulder and Elbow Surgeons (ASES) scores following arthroscopic capsular release 
      for the treatment of idiopathic shoulder adhesive capsulitis. METHODS: A 
      retrospective review of prospective collected data was performed in patients 
      undergoing arthroscopic capsular release for the treatment of idiopathic adhesive 
      capsulitis at a single institution from January 2018 through January 2019. 
      Patient-reported outcome measures were collected preoperatively and 6 months' 
      postoperatively. Delta was defined as the change between preoperative and 6 
      months' postoperative scores. Distribution-based and anchored-based (response to 
      a satisfaction question at 1 year) approaches were used to estimate MCIDs and 
      PASS, respectively. The optimal cut-off point where sensitivity and specificity 
      were maximized (Youden index) and the percentage of patients achieving those 
      thresholds were also calculated. RESULTS: Overall, a total of 100 patients 
      without diabetes who underwent arthroscopic capsular release and completed 
      baseline and 6-month patient-reported outcome measures were included. The 
      distribution-based MCID for VAS, Constant, SANE, and ASES were calculated to be 
      1.1, 10.1, 9.3, and 8.2, respectively. The rate of patients who achieved MCID 
      thresholds was 98% for VAS, 96% for Constant, 98% for SANE, and 99% for ASES. The 
      PASS threshold values for VAS, Constant, and ASES were </=2, >/=70, >/=80, and >/=80, 
      respectively. The rate of patients who achieved PASS thresholds was 84% for VAS, 
      84% for Constant, 89% for SANE, and 78% for ASES. CONCLUSIONS: In patients 
      without diabetes and idiopathic adhesive capsulitis, high rates of MCID and PASS 
      thresholds can be achieved with arthroscopic anteroinferior capsular release 
      LEVEL OF EVIDENCE: Level IV, retrospective cohort study.
CI  - Copyright (c) 2023 Arthroscopy Association of North America. Published by Elsevier 
      Inc. All rights reserved.
FAU - Pasqualini, Ignacio
AU  - Pasqualini I
AD  - Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio, U.S.A.
FAU - Tanoira, Ignacio
AU  - Tanoira I
AD  - Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
FAU - Hurley, Eoghan T
AU  - Hurley ET
AD  - Department of Orthopedic Surgery, Division of Hand and Upper Extremity, Duke 
      University, Durham, North Carolina, U.S.A.
FAU - Tavella, Tomas
AU  - Tavella T
AD  - Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
FAU - Ranalletta, Maximiliano
AU  - Ranalletta M
AD  - Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
FAU - Rossi, Luciano Andres
AU  - Rossi LA
AD  - Hospital Italiano de Buenos Aires, Buenos Aires, Argentina. Electronic address: 
      luciano.rossi@hospitalitaliano.org.ar.
LA  - eng
PT  - Journal Article
DEP - 20230915
PL  - United States
TA  - Arthroscopy
JT  - Arthroscopy : the journal of arthroscopic & related surgery : official 
      publication of the Arthroscopy Association of North America and the International 
      Arthroscopy Association
JID - 8506498
SB  - IM
MH  - Humans
MH  - Joint Capsule Release
MH  - Retrospective Studies
MH  - Treatment Outcome
MH  - Minimal Clinically Important Difference
MH  - Prospective Studies
MH  - *Shoulder Joint/surgery
MH  - *Bursitis/surgery
MH  - *Diabetes Mellitus
EDAT- 2023/09/17 00:41
MHDA- 2024/03/19 06:44
CRDT- 2023/09/16 19:17
PHST- 2023/04/02 00:00 [received]
PHST- 2023/08/28 00:00 [revised]
PHST- 2023/08/31 00:00 [accepted]
PHST- 2024/03/19 06:44 [medline]
PHST- 2023/09/17 00:41 [pubmed]
PHST- 2023/09/16 19:17 [entrez]
AID - S0749-8063(23)00770-3 [pii]
AID - 10.1016/j.arthro.2023.08.083 [doi]
PST - ppublish
SO  - Arthroscopy. 2024 Apr;40(4):1081-1088. doi: 10.1016/j.arthro.2023.08.083. Epub 
      2023 Sep 15.